Regulatory Exclusivity:
✉ Email this page to a colleague
Drugs with Regulatory Exclusivity
Click here to include patents covering these drugs in this list
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Exclusivity Expiration | Patented / Exclusive Use |
---|---|---|---|---|---|---|---|---|---|---|---|
Journey | AMZEEQ | minocycline hydrochloride | AEROSOL, FOAM;TOPICAL | 212379-001 | Oct 18, 2019 | RX | Yes | Yes | ⤷ Try a Trial | TREATMENT OF NON-NODULAR ACNE VULGARIS | |
Journey | AMZEEQ | minocycline hydrochloride | AEROSOL, FOAM;TOPICAL | 212379-001 | Oct 18, 2019 | RX | Yes | Yes | ⤷ Try a Trial | ||
Resilia Pharms | ECOZA | econazole nitrate | AEROSOL, FOAM;TOPICAL | 205175-001 | Oct 24, 2013 | RX | Yes | Yes | ⤷ Try a Trial | ||
Leo Pharma As | ENSTILAR | betamethasone dipropionate; calcipotriene | AEROSOL, FOAM;TOPICAL | 207589-001 | Oct 16, 2015 | AB | RX | Yes | Yes | ⤷ Try a Trial | TOPICAL TREATMENT OF PLAQUE PSORIASIS IN PATIENTS 12 YEARS AND OLDER |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Exclusivity Expiration | >Patented / Exclusive Use |